253 -5 (79) 2025 - Mukhamedova Sh.T., Rustamov B.B. - SURFACTANT THERAPY IN PREMATURE INFANTS: A CRITICAL TOOL IN NEONATAL CARE

SURFACTANT THERAPY IN PREMATURE INFANTS: A CRITICAL TOOL IN NEONATAL CARE

Mukhamedova Sh.T. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Rustamov B.B. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Premature birth is a major contributor to neonatal morbidity and mortality, with respiratory distress syndrome (RDS) representing one of the most critical complications. Surfactant therapy has revolutionized the management of RDS in preterm infants, significantly improving survival and reducing pulmonary complications. This article reviews the physiology of surfactant, the pathophysiology of RDS, the types of surfactant preparations available, administration techniques, timing of therapy, and current best practices

Key words: respiratory distress syndrome (RDS), very low birth weight (VLBW), Incidence of Bronchopulmonary Dysplasia (BPD), Oxygen Saturation

First page

1260

Last page

1263

For citation:Mukhamedova Sh.T., Rustamov B.B. - SURFACTANT THERAPY IN PREMATURE INFANTS: A CRITICAL TOOL IN NEONATAL CARE//New Day in Medicine 5(79)2025 1260-1263 https://newdayworldmedicine.com/en/new_day_medicine/5-79-2025

List of References

1. Polin RA, Carlo WA. Surfactant Replacement Therapy for Preterm and Term Neonates With Respiratory Distress. Pediatrics. 2014.
2. Sweet DG, et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome – 2022 Update. Neonatology.
3. Jobe AH, Ikegami M. Mechanisms Initiating Lung Injury in the Preterm. Early Hum Dev. 1998.
4. Mead, J., and Avery, M. E. (1959). Surface characteristics in connection with hyaline membrane illness and atelectasis. AMA Children's Diseases Journal, 97(5), 517-523.
5. Ikegami, M., and Jobe, A. H. (1998). mechanisms that cause lung damage in premature infants. 53(1), 81-94; Early Human Development.
6. Richmond, P., Simmer, K., Strunk, T., Currie, A., & Burgner, D. (2011). Human newborns with innate immunity: preterm is more than just immaturity. 24(1), 25–31; Journal of Maternal-Fetal & Neonatal Medicine.
7. Moss, T. J. M., and Melville, J. M. (2013). the effects of premature birth on the immune system. Neuroscience Frontiers, 7, 79.
8. Ballard, R. A., and P. L. Ballard (1995). Prenatal glucocorticoid use: scientific foundation and treatment plans. 173(1), 254-262, American Journal of Obstetrics and Gynaecology.
9. Morley, C. J., and R. F. Soll (2001). Using surfactant prophylactically as opposed to selectively can help reduce morbidity and death in premature babies. Database of Systematic Reviews, Cochrane, 2.
10. Bose, C., Van Marter, L. J., Allred, E. N., O'Shea, T. M., & Laughon, M. (2011). Developmental delay and chronic lung illness at age two in children born before 28 weeks. e726–e732 in Paediatrics, 127(3).

    file

    download